BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32966606)

  • 21. Immunophenotypic pattern of myeloid populations by flow cytometry analysis.
    Gorczyca W; Sun ZY; Cronin W; Li X; Mau S; Tugulea S
    Methods Cell Biol; 2011; 103():221-66. PubMed ID: 21722806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical and laboratory characteristics of juvenile myelomonocytic leukemia].
    Wu YY; Cai SY; Huang W; Li SS; Li W; Dong A
    Zhongguo Dang Dai Er Ke Za Zhi; 2018 May; 20(5):373-377. PubMed ID: 29764573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced myeloid specificity of CD117 compared with CD13 and CD33.
    Nomdedéu JF; Mateu R; Altès A; Llorente A; Rio C; Estivill C; López O; Ubeda J; Rubiol E
    Leuk Res; 1999 Apr; 23(4):341-7. PubMed ID: 10229319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. KMT2A-rearranged infantile acute myeloid leukemia masquerading as juvenile myelomonocytic leukemia.
    Kanayama T; Imamura T; Kawabe Y; Osone S; Tahara J; Iwasaki F; Miyagawa N; Goto H; Imashuku S; Hosoi H
    Int J Hematol; 2018 Dec; 108(6):665-669. PubMed ID: 30143999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation by Flow Cytometry of Mature Monocyte Subpopulations for the Diagnosis and Follow-Up of Chronic Myelomonocytic Leukemia.
    Picot T; Aanei CM; Flandrin Gresta P; Noyel P; Tondeur S; Tavernier Tardy E; Guyotat D; Campos Catafal L
    Front Oncol; 2018; 8():109. PubMed ID: 29707521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-proliferative effects of T cells expressing a ligand-based chimeric antigen receptor against CD116 on CD34(+) cells of juvenile myelomonocytic leukemia.
    Nakazawa Y; Matsuda K; Kurata T; Sueki A; Tanaka M; Sakashita K; Imai C; Wilson MH; Koike K
    J Hematol Oncol; 2016 Mar; 9():27. PubMed ID: 26983639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic typing of CBL, ASXL1, RUNX1, TET2 and JAK2 in juvenile myelomonocytic leukaemia reveals a genetic profile distinct from chronic myelomonocytic leukaemia.
    Pérez B; Kosmider O; Cassinat B; Renneville A; Lachenaud J; Kaltenbach S; Bertrand Y; Baruchel A; Chomienne C; Fontenay M; Preudhomme C; Cavé H
    Br J Haematol; 2010 Dec; 151(5):460-8. PubMed ID: 20955399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lineage-dependent skewing of loss of heterozygosity (LOH) of KRAS gene in a case of juvenile myelomonocytic leukemia.
    Tokuda K; Eguchi-Ishimae M; Iwabuki H; Kawakami S; Tauchi H; Ishii E; Eguchi M
    Eur J Haematol; 2015 Feb; 94(2):177-81. PubMed ID: 24766281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flow cytometry immunophenotypic findings in chronic myelomonocytic leukemia and its utility in monitoring treatment response.
    Shen Q; Ouyang J; Tang G; Jabbour EJ; Garcia-Manero G; Routbort M; Konoplev S; Bueso-Ramos C; Medeiros LJ; Jorgensen JL; Wang SA
    Eur J Haematol; 2015 Aug; 95(2):168-76. PubMed ID: 25354960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flow cytometric analysis of monocytes as a tool for distinguishing chronic myelomonocytic leukemia from reactive monocytosis.
    Xu Y; McKenna RW; Karandikar NJ; Pildain AJ; Kroft SH
    Am J Clin Pathol; 2005 Nov; 124(5):799-806. PubMed ID: 16203279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wiskott-Aldrich syndrome with unusual clinical features similar to juvenile myelomonocytic leukemia.
    Sano H; Kobayashi R; Suzuki D; Yasuda K; Nakanishi M; Nagashima T; Yamada M; Kobayashi K
    Int J Hematol; 2012 Aug; 96(2):279-83. PubMed ID: 22736231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute myeloid leukemia with t(6;9) (p23;q34): association with myelodysplasia, basophilia, and initial CD34 negative immunophenotype.
    Alsabeh R; Brynes RK; Slovak ML; Arber DA
    Am J Clin Pathol; 1997 Apr; 107(4):430-7. PubMed ID: 9124211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.
    Hall J; Foucar K
    Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spectrum of molecular defects in juvenile myelomonocytic leukaemia includes ASXL1 mutations.
    Sugimoto Y; Muramatsu H; Makishima H; Prince C; Jankowska AM; Yoshida N; Xu Y; Nishio N; Hama A; Yagasaki H; Takahashi Y; Kato K; Manabe A; Kojima S; Maciejewski JP
    Br J Haematol; 2010 Jul; 150(1):83-7. PubMed ID: 20408841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Juvenile myelomonocytic leukemia: who's the driver at the wheel?
    Niemeyer CM; Flotho C
    Blood; 2019 Mar; 133(10):1060-1070. PubMed ID: 30670449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMML.
    Yoshimi A; Balasis ME; Vedder A; Feldman K; Ma Y; Zhang H; Lee SC; Letson C; Niyongere S; Lu SX; Ball M; Taylor J; Zhang Q; Zhao Y; Youssef S; Chung YR; Zhang XJ; Durham BH; Yang W; List AF; Loh ML; Klimek V; Berger MF; Stieglitz E; Padron E; Abdel-Wahab O
    Blood; 2017 Jul; 130(4):397-407. PubMed ID: 28576879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA fingerprints in juvenile myelomonocytic leukemia (JMML) identified miR-150-5p as a tumor suppressor and potential target for treatment.
    Leoncini PP; Bertaina A; Papaioannou D; Flotho C; Masetti R; Bresolin S; Menna G; Santoro N; Zecca M; Basso G; Nigita G; Veneziano D; Pagotto S; D'Ovidio K; Rota R; Dorrance A; Croce CM; Niemeyer C; Locatelli F; Garzon R
    Oncotarget; 2016 Aug; 7(34):55395-55408. PubMed ID: 27447965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute promyelocytic leukemia: four distinct patterns by flow cytometry immunophenotyping.
    Gorczyca W
    Pol J Pathol; 2012 Mar; 63(1):8-17. PubMed ID: 22535601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
    Liu YR; Wang YZ; Chen SS; Chang Y; Fu JY; Li LD; Wang H; Yu H; Jiang B; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
    Liu YR; Chang Y; Ruan GR; Qin YZ; Lai YY; Shi HX; Wang YZ; Li LD; Jiang B; Li JL
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.